Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of camptothecin on RNA synthesis in leukemia L1210 cells.

× No keyword cloud information.

17 in total

Review 1. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors: Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal: Am J Cancer Res Date: 2017-12-01 Impact factor: 6.166

Review 2. Repair of topoisomerase I-mediated DNA damage.

Authors: Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal: Prog Nucleic Acid Res Mol Biol Date: 2006

3. Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.

Authors: G Dreyfuss; S A Adam; Y D Choi
Journal: Mol Cell Biol Date: 1984-03 Impact factor: 4.272

4. Failure to detect "cap" structures in mitochondrial DNA-coded poly(A)-containing RNA from HeLa cells.

Authors: K Grohmann; F Amairic; S Crews; G Attardi
Journal: Nucleic Acids Res Date: 1978-03 Impact factor: 16.971

5. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

Authors: T Andoh; K Ishii; Y Suzuki; Y Ikegami; Y Kusunoki; Y Takemoto; K Okada
Journal: Proc Natl Acad Sci U S A Date: 1987-08 Impact factor: 11.205

6. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors: H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal: Nucleic Acids Res Date: 1991-01-11 Impact factor: 16.971

Effects of camptothecin on RNA synthesis in leukemia L1210 cells.

Review 1. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Review 2. Repair of topoisomerase I-mediated DNA damage.

3. Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.

4. Failure to detect "cap" structures in mitochondrial DNA-coded poly(A)-containing RNA from HeLa cells.

5. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

6. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Review 7. Camptothecins: a review of their chemotherapeutic potential.

8. Mitochondrial protein synthesis: RNA with the properties of Eukaryotic messenger RNA.

9. Antiviral action of camptothecin.

10. Polymer delivery of camptothecin against 9L gliosarcoma: release, distribution, and efficacy.